Gadofosveset for Axillary Staging in Breast Cancer Patients
NCT01437865
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Breast Neoplasms
Interventions
DRUG:
Gadofosveset contrast agent enhanced MRI Axilla
Sponsor
Maastricht University Medical Center